5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS

Clinical trial NCT00339196 · COMPLETED

Trial details

NCT number: NCT00339196
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukaemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2006-07-01
Primary completion: 2008-07-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.